P. Rittenberg

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

H. Putter, C. Haie-meder, H. Kitchener, 2018, The Lancet. Oncology.

Activation of androgen receptor-associated protein 70 (ARA70) mRNA expression in ovarian cancer.

T. Brown, P. Shaw, P. Rittenberg, 2001, Gynecologic oncology.

High-risk surgical stage 1 endometrial cancer: outcomes with vault brachytherapy alone.

Keith D. Jones, M. Heywood, R. Lotocki, 2003, Gynecologic oncology.

Luteinized Thecomas ("Thecomatosis") with Sclerosing Peritonitis (LTSP): Report of 2 Cases and Review of an Enigmatic Syndrome Associated with a Peritoneal Proliferation of Specialized (vimentin+/keratin+/CD34+) Submesothelial Fibroblasts.

J. Bentley, A. Altman, S. Murray, 2016, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Stage II endometrial carcinoma: limiting post-operative radiotherapy to the vaginal vault in node-negative tumors.

M. Heywood, R. Lotocki, G. Krepart, 2005, Gynecologic oncology.

Risk of malignancy index in the evaluation of patients with adnexal masses.

K. Kieser, J. Bentley, S. Clarke, 2009, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.